Since the 1980s, selective serotonin reuptake inhibitor (SSRI) antidepressants have been the ... SSRIs and proposing the use of these drugs in new clinical applications. In this work, all ...

Around one in six people who stop antidepressants will experience withdrawal symptoms as a direct result of the medicine – lower than previous estimates, according to the largest study of its kind.

There has been a new antidepressant on the market every two or three years. In 1987, the antidepressant fluoxetine (Prozac) was introduced. It had been tested by the FDA and found to be an ...

Its appeal follows a recent report commissioned by the Department of Transport which found that more research was needed into the effects of newer antidepressants on driving performance and ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.

Additional large-scale, well-designed, comparative clinical trials evaluating the efficacy and safety of the newer antidepressants in postmenopausal women and breast cancer survivors may further ...

Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.

Thousands of bottles of the antidepressant duloxetine, which is the generic version of Cymbalta, have been recalled due to the presence of a toxic chemical, according to a notice from the Food and ...